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ABSTRACT 
 
Traditionally, Ganoderma applanatum was used as a medicinal supplement for treatment of different 
diseases. In this study, biochemical screening, acute toxicity, and impact of G. applanatum aqueous extract 
on liver and renal parameters were studied. Qualitative screening of G. applanatum aqueous extract showed 
presence of various biochemicals such as tannin, phenolics, proteins, flavanoids and other biochemicals. 
FTIR analysis also showed spectrum transmission peaks for different mycochemicals such as3248. 13cm-1 
for phenol O-H stretch, 1597.06cm-1 for primary amine N-H stretch, 783.10cm-1 for aromatic (meta disub 
benzene) C-H stretch. The extract increased body weight (Initial body weight: 181.74g; final body weight: 
185.08g) when compared to control group (Initial body weight: 178.61 g; final body weight: 181.14 g) in 
acute toxicity test dose (2000mg/kg). Similar insignificant in final body weight of animals of different 
groups were observed when compared to initial body weight of animals used for the study of live and renal 
profile. The extract had no significant effect on organ weight. Low dose (200mg kg-1) of extract 
insignificantly decrease AST (51.71±0.61 mg dL-1), ALT (146.07±0.89 mg dL-1), ALP (174.68±0.65 mg dL-1) 
and bilirubin (0.61±0.01 mg dL-1) level and significantly elevated serum albumin level (6.63±0.22 g dL-1) 
compare to control group.  Low dose (200mg kg-1) extract showed similar insignificant decrease in serum 
urea (61.30±1.05 mg dL-1) and creatinine level (0.90±0.02 mg dL-1) and significantly decreased serum uric 
acid level (19.52±1.14 mg dL-1) compare to control group of rats. Thus, dose-oriented application of G. 
applanatum extract can be beneficial for treatment of hepatic and renal diseases. 
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INTRODUCTION  
 In recent decade, interest has been paid to  
natural and alternative therapies by the people of 
many countries, which expands the use of 
medicinal plants, mushrooms, and herbal 
medicines and the use of herbal medicines for the 
treatment of various diseases has expanded 
rapidly in both developed and developing 
countries because of affordability, accessibility, 
and efficacy (Salawu et al., 2009). 
Traditionally people have been used 
medicinal mushrooms as a food supplement for 
health maintenance and as a therapeutic drug for 
the treatment of diseases. It has also been reported 
mushrooms belong to genus Ganodema have been 
used widely as alternative source of therapeutic 
agent for many diseases such as cancer, 
cardiovascular diseases, autoimmune diseases, etc. 
(Lull et al., 2005). 
Along with its beneficial effects, mushrooms 
also possess some negative impacts on body. Many 
workers reported mushroom poisoning leads          
to   gastrointestinal     discomfort,    chronic    toxicity 
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to the liver, and renal failure (Eren et al., 2010) and 
extracts of mushroom-like Pleurotus sajor-caju 
affects the renal function and decreases glomerular 
filtration rate (Tam et al., 2002). 
The World Health Organization (WHO) has 
reported that inappropriate use and practices of 
traditional medicines can have negative side 
effects and research are required to study the 
safety efficacy and to diagnose the toxicity of 
medicinal plants and mushroom for validation of 
their medicinal impacts (Wihastuti et al., 2015). 
Ganoderma applanatum is a polypore 
macrofungi with hard, woody, less fan-shaped, 
semicircular, fruiting bodies with a dull, 
unvarnished outer surface having wrinkled zones 
of brownish to grayish-brown color on carp 
surface and white color pore surface (Niemela & 
Miettinen, 2008). Macrofungi belong to genus 
Ganoderma has been traditionally used as 
medicine rather than fodder in China, Japan, and 
India for therapy of various diseases (Jeong                 
et al.,2008; Wasser, 2011). 
In this work, short term impacts of G. 
applanatum aqueous extract on hepatic and renal 
biochemical parameters of rat were studied to 
validate the medicinal efficacy of G. applanatum. 
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METHODOLOGY 
Collection of macrofungi 
Fresh fruiting body of G. applanatum (Figure 
1) was collected from Kaziranga National Park of 
Assam (26°30'N-26°45'N to93°08'E-93°36'E) and 
was match and identified on the basis of 
morphology with museum specimen by Plant 
Identification & Preservation Division of 
Department of Botany, Gauhati University, Assam 
where a voucher specimen (No. 833M) was 
deposited and another fruiting body of G. 
applanatum brought to Department of Zoology, 
Ranchi University, Ranchi for further studies. 
 
Preparation of extracts 
The fresh fruiting bodies of G. applanatum 
were initially washed by distilled water and then 
by absolute ethyl alcohol (99.8%) to avoid 
microbial contamination. The mushrooms were 
dried in shade under room temperature for six to 
seven days, powdered and sieved. As much as 50g 
of the fine powder was subjected to extraction 
chamber of Soxhlet and 300mL distilled water was 
taken in the boiling flask as extraction solvent for 
aqueous extraction. The extract obtained was 
filtered, concentrated and dried in rotary flash 
evaporator maintained at 45ºC for proper 
dehydration and the dried extracts were stored in 
airtight containers at room temperature for further 
studies (Dandapat et al., 2015). 
 
Qualitative analysis of mycochemicals 
The freshly prepared extract was used for 
mycochemical analyses. Presence of various 
biochemicals in the aqueous extract of G. 
applanatum was analyzed followed protocols 
described by Arya et al., (2012) given below. 
 
 
 
Test for carbohydrates 
Presence of carbohydrate was determined 
by addition of few drops of Molisch’s reagent to the 
test solutions (1mg mL-1 extract), this was then 
followed by addition of 1 mL concentrated H2SO4 
(98%) by the side of the test tube. The mixture was 
then allowed to stand for two minutes and then 
diluted by adding 5 mL of distilled water. The 
mixture was observed for the appearance of purple 
violet ring. 
 
Test for glycoside 
Glycoside was determined by addition of 
1mgmL-1 of extract to 3mL of anthrone reagent and 
was mixed properly. The mixture was observed for 
the appearance of the green color complex. 
 
 
Test for proteins  
Protein was estimated by addition of 0.5 
mgmL-1 of the extract and 2mL of Bradford’s 
reagent were left for few minutes. The mixture was 
observed for the appearance of blue color. 
 
Test for alkaloid 
Presence of alkaloid was determined by 
stirring of 1mgmL-1 extract with 5 mL of 1% HCl on 
hot water bath and then filtered. 1 mL of the filtrate 
was taken individually into 2 test tubes and few 
drops of Dragendorff’s reagent were added into the 
test tube. The mixture was observed for 
appearance of dark brown colour. 
 
Test for steroid 
Presence of steroid was determined by 
addition of 2mL concentrated H2SO4 (98%)           
with  2mgmL-1  of  extracts  was   mixed   vigorously. 
 
 
 
  
(a) (b) (c) 
 
Figure 1. Fruiting body of G. applanatum ((a) and (b)) and extract (c). 
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The mixture was observed for initial formation of 
red color followed by blue and finally development 
of green color. 
 
Test for triterpene 
Triterpene was estimated by addition of 
1mgmL-1 extract with one drop chloroform and 
concentrated H2SO4 (98%). The mixture was 
observed for the formation of red color. 
 
Test for phenol 
Presence of phenol was estimated by 
phenolic -catechol method. Dilute aqueous extract 
(0.5 mL of 1:10 gL-1) was pipette out in a series of 
test tubes and volume was made up to 3 ml with 
distilled water. Folin-Ciocalteau reagent (0.5mL) 
was added to each tube and incubated for 3 min. at 
room temperature and then sodium carbonate 
(20%; 2mL) solution was added, mixed thoroughly 
and the tubes were incubated for 1 minute in 
boiling water bath. The mixture was observed for 
the emergence of a blue-green color. 
 
Test for flavonoid 
Flavonoid was estimated by dissolving  
1mgmL-1extracts in water and later adding 2 mL of 
the 10% aqueous sodium hydroxide as well as 
dilute hydrochloric acid as an indicator. The 
mixture was observed for formation and 
disappearance of yellow color.  
 
Test for tannin 
Tannin was estimated by stirring0.5 mgmL-
1of the extracts with 10 mL of distilled water and 
then filtered. Few drops of 1% ferric chloride 
solution were added to   2  mL   of   the   filtrate. 
 
The mixture was observed for the formation of 
yellow precipitate. 
 
Test for saponin 
Saponin was determined by 
heating1mg/mL extracts with alcoholic KOH and 
boiled for 1 min and cooled, and then the mixture 
was acidified with 1mL of concentrated HCl.  Later 
few drops of 5% NaOH added dropwise and 
observed for froth formation. 
 
Test for lipid 
The 2 mL of extract was taken and iodine 
solution was added dropwise. Disappeared of the 
original color of iodine indicates the presence of 
lipid. The mixture was observed for disappearance 
of original color of iodine. 
 
 
 
FTIR spectra analysis 
Fourier transform infrared (FTIR) spectra 
analysis was carried out IPRresting-21 (Shimadzu 
Corp., Kyoto, Japan) in the diffuse reflectance mode 
operated at a resolution of 4 cm-1 in the range of 
400 cm-1 to 4 000 cm-1 wave number and KBr as 
standard to identify the potential biomolecules 
present in extract of fruiting body of G. applanatum. 
The FTIR machine was operated at 25±5°C, 60-
70%humidity and 240V AC (IMUSG, 2002). 
 
Analysis of impacts of G. applanatum extract on 
a rat model 
Equal numbers of male and female Wistar 
albino rats (175 to 200g) were obtained from the 
National Institute of Nutrition, Hyderabad, India. 
They were kept in a cage and maintained under 
standard laboratory conditions at ambient room 
temperature (22±3°C) and relative humidity 
(30%-65%), with dark-light cycle of 12 h for 5 
days. Rats were fed with a commercial pellet diet 
(Sadguru Shri Shri Industries Pvt. Ltd. Pune, India) 
and water. The experiment was performed after 
prior approval of the Ethics committee of Ranchi 
University, Ranchi (Proceeding no. 46, page no. 
137). 
 
Acute toxicity study 
According to OECD test guideline, 425 (Up 
and Down procedure) limited test for G. 
applanatum extract and vehicle (Distilled water) 
was performed at the test dose 2000mg/kg body 
weight (BW) with slight modification. 10 rats 
(males and females) were divided equally into two 
groups (Group-1 and Group-2) each group 
contains 5 rats. Rats were fasted (3-4hours) prior 
to dosing but were accessed with water ad libitum. 
Single-dose (2000mg kg-1) of vehicle and G. 
applanatum extract were fed by gavage using 
stomach tube to single rat of each group and were 
provided with food and water ad libitum after 
2hours. Similarly 4 other rats of each group were 
treated with G. applanatum extract and vehicle, and 
observed for 30 minutes, 4 hours and 24 hours for 
gross behavior and death due to toxicity (OECD, 
2008; Saleem et al., 2017). After treatment with 
single-dose all the animals were not treated further 
and observed till the end of 14th day for delayed 
occurrence of toxic effects such as behavioral 
changes, mortality and body, and organ weight. 
The rats were euthanized using diethyl ether as 
euthanize agent and finally cervical dislocation 
was done after 14 days. Liver and kidneys were 
removed carefully and weighed.  
 
 
Sukumar Dandapat 
 
122  Traditional Medicine Journal, 24(2), 2019 
Analysis of G. applanatum extract on hepatic and 
renal profile of rats 
To study the short term medicinal effect of 
G. applanatum extract on liver and kidney, seven 
days experimental period was chosen following 
the previous method of Garba et al, (2009). 
Therefore, therapeutic efficacy of G. applanatum 
extracts on hepatoxic and nephrotoxic rats can be 
studied further. To study the impact of extract on 
hepatic and renal profile, again 15 fresh rats (males 
and females) were taken and were distributed 
equally into three treatment groups each group 
contains 5 rats. The experiment designed for study 
of impact of extract is described below. Dose 
determination and feeding of extract were 
performed following previous method of 
Oghenesuvwe et al., (2014).  
Group-1: Rats were served as control and 
were not treated with extract and received 1mL of 
distilled water daily orally throughout the entire 
period of the experiment (7 days). 
Group 2: Rats of this group were received 
daily single LD of extract orally daily for 7 days. 
Group 3: Rats of this group were received 
daily single HD of extract orally daily for 7 days. 
At the end of the experimental period (8th 
Day) animals were lightly euthanized using diethyl 
ether and blood was collected from rats by retro-
orbital sinus blood collection method into 
evacuated voiles (SRL Diagnostic Pvt. Ltd.) 
containing clotting activator (Kumar M, 2017). 
Collected blood samples were allowed to clot and 
then centrifuged at 2000-2500 rpm and the serum 
was collected within 45 minutes of collection of 
blood samples.  Serum samples were kept at 4 °C 
for analyses of hepatic and renal profile.  After 
collection of blood the rats were finally sacrificed 
by cervical dislocation and Liver and kidneys were 
removed carefully and weighed.  
Estimation of serum hepatic and renal 
parameters was done on a semi-automatic 
chemistry analyzer: SACA-19100 (MRC Ltd., Israel) 
operated at 0-40 °C, ≤85% relative humidity and 
110V/220V±11V/22V alternative current using 
the diagnostic reagent kit by DiaSys international 
Pvt. Ltd. (Holzheim, Germany). Quantification of 
heapatic parameters such as total bilirubin, serum 
transaminases, alkaline phosphatase, and albumin 
were done by standard method of Reitman and 
Frankel, Kingsley and Frankel and Bessey et al., 
respectively and renal profile such as serum urea 
and creatinine uric acid will be estimated by Mod. 
Berthelot method and Mod. Jaffer’s method 
respectively with modification following Agrawal 
and Gupta (2013). 
 
 
Analysis of hepatic profile 
Alkaline phosphatise (ALP) 
In vitroquantification of alkaline 
phosphatase was done by a kinetic photometric 
test using alkaline phosphatase FS* DGKC kit (Cat. 
No.104019990314). A mono reagent was prepared 
by adding 20ml of R1(Diethanolamine 1.2 molL-1, 
pH 9.8   and Magnesium chloride 0.6 mmol/L) and 
5 mL of R2 (p-Nitrophenylphosphate 50 mmolL-1). 
The system was calibrated by using universal 
calibration serum (TruCal U calibrator, 
No.591009910063) at 420nm wavelength, 1cm 
optical path, 37°C against air. 20µL sample serum 
and calibrator serum were taken in cuvettes and 
1000µL monoreagent was added, mixed and 
absorbance was recorded after 1, 2 and 3 min. 
Amount of ALP in sample serum was calculated by 
using formula given below- 
 
ALP [
U
L
] 
=
Absorbance / min of sample
Absorbance/ min of calibrator
 X Conc. calibrator[U/L] 
 
Asperate aminotransferase (AST/SGOT) 
Aspartate aminotransferase (ASAT/AST), 
formerly called Glutamic oxalacetic transaminase 
(GOT). Quantitativein vitro determination of AST 
(SGOT) in serum was done photometrically by 
using ASAT (GOT) FS* (IFCC mod.) kit (Cat. 
No.126019990314). Monoreagent mixture was 
prepared by mixed 20mL R1 [TRIS 110 mmolL-1( 
pH 7.65),  L-aspartate 320 mmolL-1, MDH (malate 
dehydrogenase) ≥ 800 U/L, LDH (lactate 
dehydrogenase) ≥ 1200 UL-1] and 5mL R2 [2-
Oxoglutarate 85 mmolL-1, NADH 1 mmolL-1, 
pyridoxal-5-phosphate F8, good’s buffer (pH 9.6 
)100 mmolL-1, Pyridoxal-5-phosphate 13 mmolL-1]. 
The system was calibrated by using universal 
calibration serum (TruCal U calibrator, No. 5 9100 
99 10 063) at 365nm wavelength, 1cm optical path, 
37°C against air. 100µL sample serum and 
calibrator serum were taken in cuvettes and 
1000µL monoreagent was added, mixed and 
absorbance was recorded after 1, 2 and 3 min. 
Amount of AST in sample serum was calculated by 
using formula given below- 
 
AST [U/L]
=
Absorbance / min of sample
Absorbance/ min of calibrator
 X Conc. calibrator[U/L] 
 
Alanine aminotransferase (ALT/SGPT) 
Alanine aminotransferase (ALAT/ALT), 
formerly called glutamic pyruvic transaminase 
(GPT). Quantitative in vitro determination of ALAT  
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(GPT) in serum was done photometrically by using 
ALAT (GPT) FS* (IFCC mod.) kit (Cat. 
No.127019910023). Monoreagent mixture was 
prepared by mixed 20mL of R1 [TRIS (pH 7.15) 140 
mmolL-1, L-alanine 700 mmolL-1, LDH (lactate 
dehydrogenase) ≥ 2300 U/L] and 5mL R2 [2-
oxoglutarate 85 mmolL-1, NADH 1 mmolL-1, 
pyridoxal-5-phosphate F8 good’s buffer (pH 9.6) 
100 mmolL-1, pyridoxal-5-phosphate 13 mmolL-1]. 
The system was calibrated by using universal 
calibration serum (TruCal U calibrator, No. 
591009910063) at 340 nm wavelength, 1cm 
optical path, 37°C against air. 100µL sample serum 
and calibrator serum were taken in cuvettes and 
1000µL monoreagent was added, mixed and 
absorbance was recorded after 1, 2 and 3 min. 
Amount of ALT in sample serum was calculated by 
using the formula given below: 
 
ALT [
U
L
] 
=
Absorbance / min ofsample
Absorbance/ min of calibrator
 X Conc. calibrator[U/L] 
 
Total bilirubin (BIL) 
Quantitative in vitro determination of total 
bilirubin in serum was done photometrically by 
using Bilirubin Auto Total FS* kit (Cat. 
No.108119910023). The system was calibrated by 
using universal calibration serum (TruCal U 
calibrator, No. 591009910063, Diyasys Pvt. Ltd.) at 
560 nm, 1cm optical path, 37°C against reagent 
blank (distilled water and NaCl solution 9 gL-1). 
25µL distilled water, calibrator serum and sample 
serum were taken in cuvettes and 1000 µL R1 
[Phosphate buffer 50 mmolL-1 and NaCl 150 
mmolL-1] was added, mixed and incubated for 5 
minutes at 37 °C and then absorbance (A1) was 
taken. After taken A1, R2 [2,4-Dichlorophenyl-
diazonium salt 5 mmolL-1, HCl 130 mmolL-1] was 
mixed with previous samples and incubate for 5 
minutes at 37 °C and then absorbance (A2) was 
taken. Final absorbance was calculated (FA = F2- 
F1). Total bilirubin in the test sample was 
calculated by using formula given below- 
Bilirubin [mg/dL] =
FA  of sample
FA of calibrator
 X Conc. calibrator[mg
/dL] 
 
Total protein (TP) 
Quantitative in vitro determination of total 
protein in serum was done photometrically by 
using Total protein FS* kit [Cat. No.123119910023 
and 123009910030 (standard)]. The system       
was calibrated by using universal calibration 
serum  (TruCal  U  calibrator,   No.   591009910063, 
 
Diyasys Pvt. Ltd.) at 540 nm, 1cm optical path, 37°C 
against reagent blank (distilled water and NaCl 
solution 9 gL-1). A monoreagent was prepared by 
mixedR1 [Sodium hydroxide 100 mmolL-1, 
Potassium sodium tartrate 17 mmolL-1] and R2 
[Sodium hydroxide 500 mmolL-1, Potassium 
sodium tartrate 80 mmolL-1, Potassium iodide 75 
mmolL-1, Copper sulphate 30 mmolL-1]. 20µL 
standard (bovine serum albumin), calibrator 
serum and sample serum were taken in cuvettes 
and 1000 µL monoreagent was mixed with samples 
and incubate for 5 minutes at 37 °C and then 
absorbance was taken. Total protein in the test 
sample was calculated by using the formula given 
below: 
 
Total protein [g/dL] =
FA  of sample
FA of calibrator
 X Conc. calibrator[g/dL] 
 
Albumin (ALB) 
Quantitative in vitro determination of 
albumin in serum by photometrically using 
Albumin FS * kit [Cat. No.102209910023 and 
102009910030 (standard)]. The system was 
calibrated by using universal calibration serum 
(TruCal U calibrator, No. 591009910063, Diyasys 
Pvt. Ltd.) at 600 nm, 1cm optical path, 37°C against 
a reagent blank (distilled water and NaCl solution 
9 gL-1). 10µL standard (bovine serum albumin), 
calibrator serum and sample serum were taken in 
cuvettes and 1000 µL monoreagent was mixed 
with samples and incubate for 5 minutes at 37 °C 
and then absorbance was taken. Serum albumin in 
the test sample was calculated by using formula 
given below: 
 
Albumin [g/dL]
=
FA  of sample
FA of calibrator
 X Conc. calibrator[g/dL] 
 
Analysis of renal profile 
Serum urea 
Quantitative in vitro determination of urea 
in serum was done by photometrically using Urea 
FS* kit (Cat. No.131019910023). The system was 
calibrated by using 340nm 1cm optical path, 37°C 
against reagent blank (distilled water and NaCl 
solution 9 gL-1). A mono reagent was prepared by 
mixed 20 mL of R1 [TRIS pH 7.8 150 mmol/L, 2-
Oxoglutarate 9 mmolL-1, ADP 0.75 mmolL-1, Urease 
³ 7 kUL-1, GLDH (Glutamate dehydrogenase, 
bovine) ³ 1 kUL-1] and5 mL of R2 [NADH 1.3 
mmolL-1]. 10µL serum was taken in cuvettes and 
1000 µL monoreagent was mixed with samples    
and   incubated  for   30 – 40  seconds  at  37 °C  and 
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then absorbance was taken (A1). The absorbance 
(A2) of the sample was taken again exactly after 
another 60 seconds. Final absorbance was 
calculated (FA = A2-A1) and serum urea was 
measured using the formula given below: 
 
Urea [mg/dL] =
FA  of sample
FA of calibrator
 X Conc. calibrator[mg/dL] 
 
Serum creatinine (CREA) 
Quantitative in vitro determination of 
creatinine in serum was done photometrically by 
using Creatinine FS* kit (Cat. No.117119910023). 
The system was calibrated by using 492 nm, 1cm 
optical path, 37°C against reagent blank (distilled 
water and NaCl solution 9 gL-1). A mono reagent 
was prepared by mixed 20 mL R1 [Sodium 
hydroxide 0.2 molL-1] and 5 mL R2 [Picric acid 20 
mmolL-1]. 50µL serum sample was taken in a 
cuvette and 1000 µL mono reagent was mixed with 
samples, mixed properly and incubated for 60 
seconds at 37 °C and then absorbance was taken 
(A1). The absorbance (A2) of sample was taken 
again exactly after another 120 seconds. Final 
absorbance was calculated (FA = A2-A1) and 
serum creatinine was measured using the formula 
given below: 
 
Creatinine [mg/dL] =
FA  of sample
FA of calibrator
 X Conc. calibrator[mg
/dL] 
 
Serum uric acid (SUA) 
Quantitative in vitro determination of 
creatinine in serum was done photometrically by 
using Uric acid FS* kit (Cat. No.117119910023). 
The system was calibrated by using 520 nm, 1cm 
optical path, 37°C against reagent blank (distilled 
water and NaCl solution 9 gL-1). A mono reagent 
was prepared by mixed 20 mL of R1 [Phosphate 
buffer (pH 7.0) 100 mmolL-1, TBHBA (2,4,6-
Tribromo-3-hydroxybenzoic acid) 1.25 mmolL-1] 
and 5 mL of R2 [Phosphate buffer (pH 7.0) 100 
mmolL-1, 4-Aminoantipyrine 1.5 mmolL-1, 
K4{Fe(CN)6} 50 μmolL-1, Peroxidase (POD) ≥ 10 
kUL-1, Uricase ≥ 150 UL-1]. 20µ serum was taken in 
the cuvette and 1000 µL mono reagent was mixed 
with samples, mixed properly and incubated for 30 
minutes at 37 °C and then absorbance was taken 
(A1). The absorbance (A2) of sample was taken 
again exactly after another 60 minutes. Final 
absorbance was calculated (FA = A2-A1) and 
serum uric acid was measured using the formula 
given below- 
 
Uric acid [mg/dL] =
FA  of sample
FA of calibrator
 X Conc. calibrator[mg/dL] 
 
Statistical analysis 
Entire statistical works were done using 
full-proof statistical software WinSTAT. Data were 
taken N=5 and results were expressed as a mean ± 
standard error of mean. Statistical analysis was 
performed using Student’s t-test, p ≤ 0.05 was 
considered as statistically significant. 
 
RESULT AND DISCUSSION  
Result 
Biochemical screening 
The identified mushroom and the extract 
obtained from a dry powder of mushroom (Figure 
1). Result of biochemical analysis of crude extract 
of G. applanatum (Table I). In the present study 
different mycochemicals such as carbohydrate, 
protein, alkaloid, flavonoid, saponins, steroid, 
phenolics, etc. were found in the aqueous extract of 
fruiting body of G. applanatum. 
 
Furior transform infrared (FTIR) spectroscopy 
analysis of G. applanatum extract 
FTIR spectroscopy of G. applanatum extract 
(Figure 2). FTIR spectroscopy analysis of G. 
applanatum extract showed major transmittance 
Table I. Screening of proximate mycochemicals present in aqueous fruiting body extract of G. applanatum. 
 
Mycochemicals Present(+) or Absent (+) 
Carbohydrate + 
Glycosides + 
Protein + 
Alkaloid + 
Steroid + 
Triterpene + 
Flavonoid + 
Tannin + 
Lipid + 
Saponin + 
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peaks at 3248. 13cm-1 for phenol O-H stretch, 
2939.52cm-1 for alkyl C-H stretch, 2086.98cm-1 for  
terminal alkyne C≡C stretch, 1651.07cm-1 for 
amide C=O stretch, 1597.06cm-1 for primary amine 
N-H stretch, 1392.61cm-1 for fluro alkane C-F 
stretch, 783.10cm-1 for aromatic (metadisub 
bengene) C-H stretch, 617.22cm-1 for chloro akane 
C-Cl stretch and 520.78cm-1 for bromo alkane C-Br 
stretch. 
 
 
Acute toxicity study of G. applanatum extract 
Results of acute toxicity of G. applanatum 
extract (Table II and Table III). The results showed 
no mortality and behavioural changes such as 
convulsions, tremors, itching, shivering, 
somatomotor activity etc. due to toxicity till 14 
days in rats treated with vehicle and 2000mg/kg 
dose of extract. Slight elevation in breathing rate 
and sleeping only observed for first 30  min  in  rats 
 
 
Figure 2. FTIR spectra of G. applanatum extract. 
 
Table II.  Behavioural patterns of rats treated with vehicle and G. applanatum extract in acute toxicity test. 
 
Groups of rats 
 
Parameters 
Group-1 Group-2 
30 Min. 4 Hrs. 24 Hrs. 14Day 30 Min. 4 Hrs. 24 Hrs. 14Day 
Fur & skin N N N N N N N N 
Eyes N N N N N N N N 
Salivation N N N N N N N N 
Breathing I N N N I N N N 
Somatomotor 
activity & behavior 
pattern 
N N N N N N N N 
Sleep N N N N N I N N 
Convulsions & 
tremors 
NF NF NF NF NF NF NF NF 
Itching NF NF NF NF NF NF NF NF 
Coma NF NF NF NF NF NF NF NF 
Death NF NF NF NF NF NF NF NF 
 
Note: N=normal, NF= not found, I=increase 
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of both groups (Table II). The result of acute toxic 
impact of extract on body weight and organ weight 
is in Table III. The result showed insignificant 
increase in final BW of rats treated with vehicle 
(182.98±1.27g) and G. applanatum extract 
(183.76±0.75g) compared to initial BW of animals 
treated with vehicle (181.65±1.49g) and G. 
applanatum extract (181.58±1.09g). No significant 
differences in weight of liver (5.53±0.36g) and 
kidneys (1.58±0.11g) were also observed in rats 
treated with 2000mg/kg dose of extract compared 
to weight of liver (5.52±0.38g) and kidneys 
(1.60±0.13g) of rats treated with vehicle. 
 
Effect of 200mg/kg and 400mg/kg G. 
applanatum extract on body and organ weight 
and behavioral changes 
Effects of G. applanatum extract (200mg/kg 
and 400mg/kg) on behavioral changes, body, and 
organ weight (Table IV and V). Mortality and 
behavioral changes such as convulsions, tremors, 
itching, shivering, somatomotor activity, etc. Were 
not observed in any treatment group. Insignificant 
increase in final body weight was observed in rats 
of group-2 (185.82±2.17g) and group-3 
(187.04±2.44g) compared to group-1 
(184.70±2.77g). Both 200mg/kg and 400mg/kg 
extract showed insignificant change in weight of 
kidney in group-2 (1.64±0.10g) and group-3 
(1.64±0.13g) compared to group-1 (1.64±0.12). 
Similarly impact of extract in weight of liver also 
observed among the treatment groups. 
Effect of G. applanatum extract on hepatic 
profile  
Result of G. applanatum extracts on hepatic 
profile of rat is Table VI. The 200 mg kg-1 dose of 
extract showed insignificant decrease in ALP 
(174.68±0.65 mgdL-1), AST (51.71±0.61 mg dL-1), 
ALT (146.07±0.89 mg dL-1), total bilirubin 
(0.61±0.01 mg dL-1) and showed insignificant 
increase in total protein (9.02±0.17 gdL-1) 
compared to ALP (176.24±0.57 mgdL-1), AST 
(52.32±0.70 mg dL-1), ALT (146.63±0.78 mg dL-1), 
total bilirubin (0.62±0.01 mg dL-1) and total 
Table III. Body weight and organ weight of rats treated with vehicle and G. applanatum extract in acute 
toxicity test. 
 
Treatment groups 
 
 
Body weight and organ weight (in g) 
Group-1 Group-2 
Initial body weight  181.65±1.49 181.58±1.09 
Final body weight  182.98±1.27 183.76±0.75 
Weight of liver  5.52±0.38 5.53±0.36 
Weight of kidneys  1.60±0.13 1.58±0.11 
 
Table IV. Behavioural patterns of different treatment groups of rats used to study impact of G. applanatum 
extract on hepatic and renal profiles. 
 
Groups of rats 
 
Parameters 
Group-1 Group-2 Group-3 
30 
Min. 
4 
Hrs. 
24 
Hrs. 
7Dy 30 
Min. 
4 
Hrs. 
24 
Hrs. 
7Dy 30 
Min. 
4 
Hrs. 
24 
Hrs. 
7Dy 
Fur & skin N N N N N N N N N N N N 
Eyes N N N N N N N N N N N N 
Salivation N N N N N N N N N N N N 
Breathing I N N N I N N N I N N N 
Somatomotor 
activity & behavior 
pattern 
N N N N N N N N N N N N 
Sleep N N N N N I N N N I N N 
Convulsions & 
tremors 
NF NF NF NF NF NF NF NF NF NF NF NF 
Itching NF NF NF NF NF NF NF NF NF NF NF NF 
Coma NF NF NF NF NF NF NF NF NF NF NF NF 
Death NF NF NF NF NF NF NF NF NF NF NF NF 
 
Note: N=normal, NF= not found, I=increase 
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protein (8.57±0.24 gdL-1) of control group. Only 
significant (p ≤ 0.05) in albumin of group-1 
(6.63±0.22 g dL-1) was observed compared to 
control group (4.23±0.31 g dL-1). 400 mg kg-1 dose 
of extract showed high efficacy than 200 mg kg-1 
dose of extract (Table V). Significant (p ≤ 0.05) 
decrease in ALP (173.79±0.98) and increase in 
protein (9.51±0.30 g dL-1) and albumin (7.32±0.42 
g dL-1) were observed in rats treated with 400 mg 
kg-1 dose of   extract   compared   to   control   group.  
400 mg kg-1 dose of extract had no significant effect 
on total bilirubin, AST, ALT compared to values of 
the control group. 
 
Effect of G. applanatum extract on renal profile 
of rat 
Result of G. applanatum extracts on hepatic 
profile of rat (Table VII). The LD of extract (200 mg 
kg-1) significantly (p<0.05) decreased serum uric 
acid (19.52±1.14 mg dL-1) in rats of group-2 
compared to control (22.5±0.70 mg dL-1). 400 mg 
kg-1 dose of extract showed high efficacy than low 
dose (200 mg kg-1) and significantly (p<0.05) 
decreased serum urea (57.62±0.74 mg dL-1), 
creatinine (0.86±0.02 mg dL-1) and uric acid 
(14.24±0.73 mg dL-1) in rats of group-3 compared 
serum urea (62.32±1.17 mg dL-1), creatinine 
(0.93±0.01 mg dL-1) and uric acid (22.5±0.70 mg 
dL-1) in rats of control group.  
 
Discussion 
Fruiting bodies of Ganoderma spp. have 
been used in traditional medicine and used in 
variety of products in the form of coffee, powder, 
dietary supplements, spore products, drinks, 
syrups, toothpastes, soaps and lotions (Lai et al., 
2004) because of their various therapeutic 
biochemicals (mycochemicals) composition such 
as reducing sugars, amino acids, phenolic 
compounds, flavonoids, glycosides terpenoids etc. 
(Singh et al., 2014). In the present study 
mycochemical screening of G. applanatum extract 
(Table I) showed presence of similar 
mycochemicals        as         previously         reported 
Table V. Body and organ weight of different treatment groups of rats used to study impact of G. applanatum 
extract on hepatic and renal profiles. 
 
Groups of rats 
 
 
Body weight and Organ 
weight (in g) 
Group-1 Group-2 Group-3 
Initial body weight  182.44±2.72 182.46±2.16 184.74±2.52 
Final body weight  184.70±2.77 185.82±2.17 187.04±2.44 
Weight of liver  5.47±0.22 5.47±0.23 5.49±0.24 
Weight of kidneys  1.64±0.12 1.64±0.10 1.64±0.13 
 
Table VI. Effect of G. applanatum extract on hepatic profile; N=5±SE of mean; *=p<0.05, **=p<0.025, 
***=p<0.0005. 
 
Groups of rats 
Parameters 
Group-1 Group-2 Group-3 
ALP (mgdL-1) 176.24±0.57 174.68±0.65 173.79±0.98* 
AST(mg dL-1) 52.32±0.70 51.71±0.61 50.62±1.04 
ALT(mg dL-1) 146.63±0.78 146.07±0.89 145.32±0.89 
Bilirubin total (mg dL-1) 0.62±0.01 0.61±0.01 0.60±0.01 
Protein(g dL-1) 8.57±0.24 9.02±0.17 9.51±0.30** 
Albumin(g dL-1) 4.23±0.31 6.63±0.22*** 7.32±0.42*** 
 
Table VII. Effect of G. applanatum extract on renal profile of rat; N=5±SE of mean; *=p<0.05, **=p<0.005; 
***=p<0.0005. 
 
Groups of rats 
Parameters 
Group-1 Group-2 Group-3 
Serum urea(mg dL-1) 62.32±1.17 61.30±1.05 57.62±0.74** 
Serum creatinine(mg dL-1) 0.93±0.01 0.90±0.02 0.86±0.008** 
Serum uric acid(mg dL-1) 22.5±0.70 19.52±1.14* 14.24±0.73*** 
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mycochemical screening of Ganoderma 
spp.Previous FTIR analysis showed Ganoderma 
lucidum extract contains high protein and 
carbohydrates with spectra transmission peaks      
of  1800  to 1400  cm-1  and   889  cm-1  respectively 
(Keonget al., 2012). In the present study FTIR 
analysis of G. applanatum extract (Figure 2) also 
provised transmission spectra for phenols, amines 
and other compounds. 
The World Health Organization and Food 
and Drug Administration have recommended that 
acute and chronic toxicological evaluation of 
herbal medicines (medicinal plants and fungal 
origin) must be done for the appropriate 
ethnomedicinal uses (Subramanion et al., 2011; 
Saleem, U., 2017).General behavioral patterns and 
body weights are one of the critical indicators for 
the evaluation of early signs of acute toxicity of 
drugs (Sireeratawong et al., 2008). In the present 
study mortality and adverse behavioral changes 
and toxic outcome on the body were not observed 
in the animal groups during the acute toxicity 
experimental period (Table II) and in treatment rat 
groups (Table IV) used for the study to see the 
medicinal impact G. applanatum extract on liver 
and renal profile.  
Proper food and water intake did not 
produce a concomitant decrease in the bodyweight 
but change in the body weights due to intake of any 
medicinal supplement is one of the first critical 
signs of toxicity (Sireatawong et al., 2008). It has 
also been reported that adverse interaction of the 
herbal extract with the major organs cause cellular 
constriction and inflammation, which usually 
reflects in the significant changes in weight of vital 
organs such as liver and kidney (Devaki et al., 
2012). In the present study body weight of rats 
increased, used in acute toxicity test and rats 
(Table III) used to study to see the medicinal 
impact G. applanatum extract on liver and renal 
profile (Table V). The G. applanatum extract 
showed insignificant variation in the weight of 
liver and kidneys after treatment. The increase in 
body weight of rats showed insignificant 
differences between initial and final body weight. 
Thus, it can be said that the biochemicals of G. 
applanatum extract are associated with normal 
function of liver and kidneys and proper 
processing of lipids, carbohydrates and protein 
metabolism inside body because these nutrients 
play a major role in different physiological 
functions of the body (Kuatsienu et al., 2017; 
Saleem et al., 2017).  
Analysis of certain serum biochemical 
parameters for specific organs such as kidneys and 
the liver, provide useful information regarding the 
mechanisms of toxicity and safe therapeutic use of 
drugs (Yamthe I et al., 2012). The liver is the main 
organ of body plays biotransformation and 
disposition of xenobiotics and liver underexposure 
of large concentrations of exogenous substances 
such as drugs and their metabolites modulate the 
properties of hepatotoxicant by either increasing 
its toxicity or by detoxification (Kedderis, 1996; 
Singh et al., 2011).Liver function tests conducted 
through serological assays provide information 
about the status of liver and its proper function, 
cellular integrity and its link with the biliary tract 
(Agbaje et al., 2009). 
Levels of hepatic enzymes such as AST, ALT, 
ALP and total protein, albumin, and bilirubin are 
widely used as sensitive markers for assessment of 
toxic effects in the liver (Mukinda & Syce, 2007). 
AST and ALT are two major hepatic enzymes 
increase the in the serum because of damage of 
hepatocytes (Ali et al., 2008; Ogunlana et al., 2013). 
However, ALP is the major standard biomarker of 
biliary tract obstruction (Saleem et al., 2017).It has 
been reported that low levels of ALP occur in 
several diseases such as hypothyroidism, 
pernicious anaemia, zinc deficiency and congenital 
hypophosphatasia (Gowda et al., 2009).Bilirubin is 
produced by the metabolism of heme derived from 
damaged red blood corpuscles and increase level 
of bilirubin in serum represents chronic liver 
injuries, but not in mild liver injuries (Bigoniya et 
al., 2009).Estimation of total proteins in the body is 
helpful in differentiating between a normal and 
damaged liver function because the major plasma 
proteins like albumins are produced in the liver 
(Thapa & Walia, 2007). Previous researches 
reported that increased protein and albumin level 
indicate liver dysfunctions which impair protein 
synthesis (Rajesh SV, 2009). However, according to 
clinical biochemistryhepatic damage leads to 
decrease in albumin production and decrease total 
protein level of blood plasma (Thapa & Walia, 
2007; Singh et al., 2011). In the present 
investigation LD of G. applanatum extract in 
significantly decrease ALT, AST, ALP and total 
bilirubin in serum (Table VI). However, HD of G. 
applanatum extract significantly modulated total 
protein and albumin level and helps elevated total 
albumin level. Hence, both LD and HD of G. 
applanatum extract showed non-toxic impact to 
liver but increase the efficiency of liver. Previous 
studies reported that, mycochemicals of edible 
medicinal mushrooms and Ganoderma spp. extract 
improve status of damaged liver in 
hepatotoxicated rats by suppressing the high 
serum ALT, AST, ALP and total bilirubin level and 
elevate total protein and albumin level (Mishra & 
Singh, 2013; Eroglu &Beytut, 2018). Result of 
present study correlates with previous studies and 
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supports the hepato tonic potentiality of G. 
applanatum. 
Protein and nitrogen metabolism is 
necessary for normal health and they are derived 
from dietary protein intake, which is necessary for 
protein synthesis and maintenance of muscle, and 
excess of unwanted amino acids are degraded and 
converted to urea in the liver and removed through 
excretion by the kidneys (Weiner et al., 2015). It is 
important to know about urea functions and 
metabolism because urea is the major circulating 
source of nitrogen-containing compounds and it 
plays important roles in regulating kidney function 
and uremic symptoms occurs due to the 
accumulation of ions and toxic compounds in body 
fluids and improper renal function (Mitch & 
Fouque, 2012; Weiner et al., 2015). Creatinine is 
formed endogenously in the muscle during muscle 
protein metabolism by non-enzymic action on 
creatine phosphate (Mayes, 1988; Nwankpa et al., 
2018). Creatinine is excreted along with urea in the 
glomerulus of the kidney and its assessment is a 
useful tool to assess the functionality of the kidney 
(Ifeanacho, 2017). In present investigation LD and 
HD of G. applanatum extract insignificantly and 
significantly decreases serum urea level but both 
doses of the extracts insignificantly decrease 
creatinine level (Table VII). The previous study 
reported that natural substance having high 
antioxidant activity and free radical scavenging 
activity effectively eliminates the urea and 
creatinine through excretion and decreases the 
serum urea and creatinine level (Mehrdad et al., 
2007). It has also been reported that mushroom 
belongs to Ganoderma have high antioxidant 
capacity and their supplements reduced renal 
pathology by decreasing serum urea and creatinine 
concentration (Zhong et al., 2015; Abdullah et al., 
2018). Uric acid is the end product of endogenous 
purine metabolism and its production and 
metabolism involving various factors that regulate 
hepatic production, renal and gut excretion of this 
compound (Simao et al., 2012). Endogenously uric 
acid is mainly produced from the liver, intestines 
and other tissues like muscles, kidneys and the 
vascular endothelium (Chaudhary et al., 2013 
Maiuolo et al., 2016).It has been reported that 
elevated serum levels of uric acid play an 
important role to promote many disease such as 
gout, articular degenerative disorders, vascular 
inflammation, and atherosclerosis and adversely 
change renal vasculature to promote chronic renal 
disease (Isekiet al., 2001; Maiuolo et al., 2016; 
).Previous studies have been reported that, 
mushroom carbohydrates especially 
polysaccharides, flavonoids, polyphenolic and 
other mycochemicals decrease high serum uric 
acid level by suppressing liver xanthine oxidase 
activity which is one of the major catabolic agents 
involves in the formation of uric acid  and free 
radical generation (Ma et al., 2014; Vanishree et al., 
2017). Previously it has also been reported that 
Ganoderma  extract showed hypouricemic effects, 
mediated through renal organic anion transporter 
1, glucose transporter 9;, and uric acid transporter 
1 and gastrointestinal concentrative nucleoside 
transporter 2 which elevate urine uric secretions 
and decline in the absorption of purine in the 
gastrointestinal tracts lead to decline serum uric 
acid level(Yong et al., 2018). In present study LD of 
G. applanatum extract showed insignificant 
decrease serum creatinine level. The LD and HD of 
extract insignificantly and significantly decrease 
serum urea level. Both the doses of G. applanatum 
extract showed high hypouricemic activity (Table 
IV), correlates and supports previous studies. 
 
CONCLUSION 
G. applanatum extract showed presence did 
not show any acute toxic impact and mortality and 
associated with significant elevation of body 
weight.  The extract also showed a negative sub-
acute toxic impact on hepatic and renal 
biochemical parameters. The extract of G. 
applanatum served as hepato tonic activity by 
elevation of serum albumin level and the extract 
also showed nephroprotective activity by decrease 
serum urea and uric acid level. Thus, dose oriented 
application G. applanatum extract can prevent the 
liver and kidney toxicity and the extract can be 
used in chronic renal and hepatic diseases. 
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